Paul Laikind, PhD, Joins Stemson Therapeutics Board of Directors
April 18, 2022
Stemson Therapeutics announced today that Paul Laikind, serial entrepreneur and former CEO of cell therapy company ViaCyte, has joined the Stemson Board of Directors. Paul brings significant company building and therapeutics development experience to the Stemson Board.